Variant · Fusion
MEF2D Fusion
CI-VAR-00001444Explore in graph →CIViC 5055
Curated evidence
Evidence by cancer (3 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 36309560
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| B-lymphoblastic Leukemia With MEF2D Rearrangement3unmapped disease | ||||||||
| MEF2D::v Fusion | (diagnostic) | Diagnostic | B | Supports Positive | 3 | accepted | EID12176This international, multi-center retrospective analysis examined characteristics of 107 cases of B- lymphoblastic leukemia (B-ALL) with MEF2D gene rearrangements (MEF2D-r), gathering information from… (full text at CIViC) PMID 36309560 · Ohki et al., 2023 · Open in CIViC | civic |
| MEF2D::v Fusion | (diagnostic) | Diagnostic | B | Supports Positive | 4 | accepted | EID12178This study gathered diagnostic and prognostic data from pediatric B-cell acute lymphoblastic leukemia (B-ALL) patients stored in the Tokyo Children’s Cancer Study Group (TCCSG) biobank. Among the 328 … (full text at CIViC) PMID 30171027 · Ohki et al., 2019 · Open in CIViC | |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available